A phase I trial of MB-103 to the brains of patients with HER2-positive breast cancer with brain metastases
Phase of Trial: Phase I
Latest Information Update: 30 Oct 2018
At a glance
- Drugs MB-103 (Primary)
- Indications Brain metastases; Glioblastoma
- Focus Adverse reactions; First in man; Therapeutic Use
- 30 Oct 2018 According to a Mustang Bio media release, this trial is being conducted by City of Hope, a world-renowned independent cancer research and treatment centre.
- 30 Oct 2018 Status changed from planning to recruiting, according to a Mustang Bio media release.
- 02 Nov 2017 New trial record